# NeuMoDx Molecular

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/neumodx-molecular

- Industry: Medical Devices & Equipment
- Headquarters: Ann Arbor, US
- Website: www.neumodx.com
- Total disclosed funding: $26M
- Latest round: Series B (Apr 1, 2014)
- Investors on record: 6

## About

Established in 2013 and based in Michigan, US, NeuMoDx Molecular, Inc. operates as a molecular diagnostics company which develops solutions for molecular diagnostic testing.

## Funding rounds

- Series B, Apr 1, 2014, $21M — Baird Capital Partners, Venture Investors, Arboretum Ventures, University of Michigan (Ross School of Business), Pfizer Venture Investments
- Series A, Apr 1, 2012, $5M — Wolverine Venture Fund

## Investors

- Wolverine Venture Fund (https://capitalatlas.ai/funds/wolverine-venture-fund) — Series A
- Baird Capital Partners (https://capitalatlas.ai/funds/baird-capital-partners) — Series B
- Venture Investors — Series B
- Arboretum Ventures (https://capitalatlas.ai/funds/arboretum-ventures) — Series B
- University of Michigan (Ross School of Business) (https://capitalatlas.ai/funds/university-of-michigan-ross-school-of-business) — Series B
- Pfizer Venture Investments (https://capitalatlas.ai/funds/pfizer-venture-investments) — Series B